Cargando…
How to Respond to the US Food and Drug Administration's Report on Squamous Cell Carcinoma in Breast Implant Capsules
Autor principal: | Teitelbaum, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264221/ https://www.ncbi.nlm.nih.gov/pubmed/37018473 http://dx.doi.org/10.1093/asj/sjad088 |
Ejemplares similares
-
Analysis of US Food and Drug Administration Breast Implant Postapproval Studies Finding an Increased Risk of Diseases and Cancer: Why the Conclusions Are Unreliable
por: Swanson, Eric
Publicado: (2019) -
Histological Characterization of Human Breast Implant Capsules
por: Bui, Janine M., et al.
Publicado: (2015) -
Erratum to: Histological Characterization of Human Breast Implant Capsules
por: Bui, Janine M., et al.
Publicado: (2015) -
The clinical pharmacogeneticist: An emerging regulatory scientist at the US Food and Drug Administration
por: Zineh, Issam, et al.
Publicado: (2010) -
Primary Squamous Cell Carcinoma Arising from a Breast Implant Capsule
por: Zomerlei, Terri A., et al.
Publicado: (2016)